Clinical Trial Update: Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of interleukin-2 and stem cell factor in patients with AIDS- or AIDS-related lymphoma; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Drugs mentioned

• Interleukin-2 (interleukin-2)
• Stem cell factor (stem cell factor)

Snippet

Sponsor: Roswell Park Cancer Institute | Conditions: Lymphoma | Phase 1 | Status: COMPLETED